Introduction
============

Cadmium is a well-known toxic metal widely distributed in the environment. Cadmium compounds are present in various products such as plastic stabilizers, color pigment, several alloys, certain batteries, and phosphate fertilizers ([@B17]). Cadmium intoxication in the general population can occur through cigarette smoking, habitual intake of contaminated food or water and by inhalation of polluted air ([@B40]). Each cigarette contains approximately 1\~2 ug of cadmium, with 40-60% of that being absorbed through the lungs directly into the systemic circulation ([@B2]). The major contaminated sources of dietary cadmium are fish, liver, grains, leafy vegetables, potatoes, and other root vegetables. Once absorbed, cadmium has a long biological half-life of 10 to 30 years and its excretion from the body is extremely low ([@B30]). Therefore, it accumulates in various tissues such as kidneys, lung, liver, bone, testis and placenta ([@B7]). Studies have shown that chronic cadmium exposure even at low levels leads to a variety of illness including kidney dysfunction, osteoporosis, early onset of diabetic renal complications, hypertension, and increased cancer risk ([@B18]; [@B33]). The metal and its compounds are in fact classified as group 1 carcinogens for humans ([@B15]).

Studies on cadmium toxicity have revealed diverse cellular targets for the deleterious action of this toxic metal. Among them, growing evidence has accumulated that cadmium perturbs the homeostasis of essential metals, especially iron. For example, the production of erythropoietin, an important regulator of iron metabolism in the body, is markedly decreased in cadmium poisoned kidneys ([@B13]; [@B31]). Furthermore, other important steps of iron homeostasis, such as iron absorption from the diet, contribute to cadmium toxicity. In the case of iron deficiency, production of divalent metal transporter 1 (DMT1), an iron importer that is located in the apical membrane of enterocytes, is significantly increased ([@B11]). Interestingly, the induction of DMT1 was shown to be associated with increased cadmium burden in mice fed an iron-deficient diet ([@B29]). DMT1 can transport several other divalent metal ions in addition to iron, including cadmium ([@B5]). Therefore, investigations on the role of cadmium in the regulation of iron transporters would be useful to better understand the interactions between iron and cadmium metabolism.

Macrophages play a key role in maintaining body iron homeostasis. Especially, macrophages of reticuloendothelial system, such as Kupffer cells in the liver and macrophages of spleen and bone marrow, provide most of the iron required for erythropoiesis by recycling iron from senescent erythrocytes ([@B39]). Iron recycling by macrophages represents the largest pathway of intracellular iron export into the blood system ([@B9]). Ferroportin-1 (FPN1/MTP1/SLC40A1) is a transmembrane transporter protein that plays a key role in the export of iron ([@B1]; [@B8]; [@B23]). Several mutations in the human *FPN1* gene were unequivocally associated with iron accumulation within macrophages, suggesting a critical role of FPN1 in the release of iron from macrophages. Some divalent metals, such as iron and copper, have been shown to affect the level of FPN1 gene expression *in vivo* and *in vitro* ([@B6]; [@B19]). It has not yet been determined whether environmentally toxic metals like cadmium can influence FPN1 expression. In the present study, we examined the effects of cadmium on the regulation of FPN1 gene expression in J774 macrophage cells.

Materials and Methods
=====================

Cell cultures and treatment
---------------------------

J774 mouse macrophage cells were cultured in α-minimum essential medium (α-MEM) supplemented with 10% fetal bovine serum and antibiotics. Before treatments, cells were seeded in a 6-well plate and grown to 60\~80% confluence. Stock solutions of CdCl~2~, actinomycin D, and N-acetylcystein (NAC) were prepared in PBS (pH 7.4) and sterilized by filtration with 0.2 µm membrane.

RT-PCR analysis
---------------

Total RNA was isolated from the treated cell with Trizol® reagent (Invitrogen, USA). Reverse transcription was carried out with l µg RNA samples by using Reverse transcription master premix (ELPIS biotech, Korea) at 42℃ for 60 min followed by inactivation of reverse transcriptase at 94℃ for 5 min. RT-PCR was performed on MJ mini gradient thermal cycler (Bio-Rad, USA). RT-PCR conditions were 95℃ for 30s, 65℃ for 30s, 72℃ for 1 min with a final extension at 72℃ for 10 min. The primer sets were FPN1 (forward) TTGCAGGAGTCATTGCTGCTA, (reverse) TGGAGTTCTGCACACCATTGAT; β-actin (forward) CTGGCACCACACCTTCTA, (reverse) GGGCACAGTTGGGTGAC (Xenotech, Korea). PCR products were separated on a 2% agarose gel containing ethidium bromide and bands were analyzed with Gel Doc XR system (Bio-Rad, USA) and Quantity on 1-D analysis software (Bio-Rad, USA). For each experiments, the relative abundance value obtained by densitometric analysis was normalized to the value derived from the control sequence (β-actin) in the corresponding sample.

Luciferase reporter assay
-------------------------

FPN1 promoter/luciferase reporter gene construct (FPN1-Luc, a gift from Dr. Haile, University of Texas at San Antonio, USA) was used for this experiment. The FPN1-Luc plasmid consists of \~2.6 kb of FPN1 5\' promoter region, all of the 5\'-untranslated region (5\'-UTR) including IRE, and firefly luciferase coding sequence. Empty vector that contains firefly luciferase coding sequence only was used as a negative control. For transient transfection, HeLa cells were seeded at 2.7 × 10^5^ cells in a 6-well plate and grown to \~60% confluence. FPN1-Luc plasmid was transiently transfected into HeLa cells using PolyFect® transfection reagent (QIAGEN, USA) according to manufacturer\'s manual. At 12-h after transfection, cells were washed and divided, and then treated with various concentrations of CdCl~2~ for 8 h. After metal treatments, cell lysates were prepared using 1× lysis buffer. Luciferase activity was measured with a luminometer using a luciferase reporter assay system (Promega, USA).

Western blot analysis
---------------------

After cadmium treatment, cells were washed three times with PBS and lysed in a lysis buffer containing 4× Tris/SDS (pH 6.8), 5% β-mercaptoethanol, and protease inhibitor cocktails. After DNA shearing, protein concentrations of lysates were determined by RC DC Protein assay (Bio-Rad, USA). Fifteen micrograms of cell lysates were separated by SDS/polyacrylamide gel electrophoresis, and transferred to PVDF membranes. The membranes were stained with Ponceau-S solution to visualize and confirm that equal amounts of protein were transferred among wells. After rinsing Ponceau-S solution, the membranes were blocked with 5% skim milk in Tris-buffered saline (TBS) containing 0.01% Tween 20 for at least 1\~2 hour. Blocked membrane was incubated with affinity purified anti-FPN1 antibody (1:100) overnight at 4℃. The membrane was then washed with TBS-T for 30 min and incubated with secondary anti-rabbit IgG peroxidase-linked antibody (Amersham, USA, 1:5,000) in 2.5% skim milk/TBS-T for at least 1 hour at room temperature. Specific bands were visualized with an enhanced chemiluminescence system (ELPIS biotech, Korea). Intensities of the bands were quantified using a Gel Doc XR system (Bio-Rad, USA) equipped with Quantity one 1-D analysis software (Bio-Rad, USA).

Determination of intracellular ROS production
---------------------------------------------

Intracellular ROS was detected by the oxidation-sensitive fluorescent probe dye, 2\',7\'-dichlorodihydrofluorescein diacetate (H~2~DCFDA) (Invitrogen Molecular Probes, OR, USA). This dye is a stable nonpolar compound which diffuses readily into the cells. Intracellular ROS in the presence of peroxidase changes this dye to the highly fluorescent compound DCF. Thus, the fluorescent intensity is proportional to the amount of peroxides which are produced by the cells. Following exposure to cadmium for 2 hours, the cells were collected and washed with ice-cold PBS. We then added 1 ml of PBS containing 10 µM DCFH-DA, and incubated the cells for 30 min at 37℃. The fluorescence emission from DCF was analyzed via FACSscan flow cytometry (Becton-Dickinson, CA, USA).

Measurements of glutathione
---------------------------

The concentration of glutathione (GSH and GSSG) in cellular lysates was determined according to the methods of Rahman et al. ([@B27]). Briefly, washed cells were lysed by repeatedly freezing and thawing using lysis buffer containing 0.6% (w/v) sulfosalicylic acid, 0.15 (v/v) Triton X-100, 5 mM EDTA in 0.1M potassium phosphate buffer, pH 7.5. The supernatant was collected after centrifugation and incubated with 0.2 mg/ml dithiobisnitrobenzoic acid (DTNB) and 1.67 U/ml glutathione reductase in phosphate buffer-EDTA for 30 s, then 0.2 mg/ml β-NADPH was added and the rate of DTNB reduction was spectrophotometrically measured at 405 nm. GSH content was calculated using a standard curve, and expressed as nmol/mg protein. For GSSG measurements, the cell supernatants were first mixed with 2-vinylpyridine and incubated at room temperature for 1 h. After incubation, triethanolamine was added and GSH assay were repeated.

Statistical analysis
--------------------

All experiments were repeated three or four times on separate occasions. Statistical analysis was performed by using the SAS systems (ver. 9.1). Differences between groups were tested by ANOVA followed by Duncan\'s multiple comparison test. All data were expressed as mean ± SD. *P* values less than 0.05 were considered significant.

Results
=======

Effects of cadmium on FPN1 mRNA and protein levels in J774 macrophages
----------------------------------------------------------------------

To determine cadmium treatment conditions that are non-toxic to J774 cells, we first evaluated the effects of cadmium treatment at various doses and time on the viability of macrophage cells in culture using the MTT assay. J774 macrophage cells (5×10^4^/well, 96 well-plates) were treated with CdCl~2~ at indicated concentrations for 8, 12 or 20 hours, and incubated with MTT reagent for 4 hours. As shown in [Fig. 1](#F1){ref-type="fig"}, there was a significant loss of viability when the concentrations of CdCl~2~ was equal to or higher than 50 µM, where the number of viable cells was 60% and 46% of the control after 12 and 20 hours of exposure, respectively. 100 µM CdCl~2~ further decreased the viable cell numbers to 37% and 27% of the controls after 12- and 20- hour treatment, respectively. On the other hand, incubation of J774 cells with CdCl~2~ at concentrations of 5 to 25 µM for 8 hours had no significant effect on cell viability. Accordingly, cells were treated with CdCl~2~ at a concentration lower than 25 µM for shorter than 8 hours in all subsequent experiments to ensure the treatment was noncytotoxic.

To examine whether cadmium affects FPN1 mRNA levels, J774 cells were incubated with different concentrations of CdCl~2~ (5\~25 µM) for 8 hours and total RNAs were extracted for RT-PCR analyses. The results of this analysis showed that cadmium induced FPN1 mRNA expression in a dose-dependent manner. As shown in [Fig. 2](#F2){ref-type="fig"}, the induction of FPN1 mRNA was evident at 5 µM and increased linearly upon incubation with concentrations up to 25 µM. Quantification of FPN1 mRNA levels normalized to β-actin mRNAs levels revealed a 1.5-, 2.5-, and 3- fold increase by 5, 10, and 25 µM CdCl~2~, respectively. To examine the time required for cadmium-induced FPN1 mRNA expression, cells were treated with 25 µM CdCl~2~ for 0, 1, 2, 4 or 8 hours. In these experiments, we found that FPN1 was readily induced by cadmium as early as 4 hours and increased further after 8 hours ([Fig. 3](#F3){ref-type="fig"}).

We further examined whether the elevated FPN1 mRNA levels by cadmium treatment were associated with an increase in FPN1 protein levels by Western blot analyses. Basal levels of FPN1 protein in untreated J774 cells were very low, but when cells were treated with 5\~25 µM CdCl~2~ for 8 hours, FPN1 protein levels were greatly increased in a dose-dependent manner ([Fig. 4](#F4){ref-type="fig"}).

Effects of cadmium on the transcription of FPN1 in macrophage cells
-------------------------------------------------------------------

To investigate the molecular basis for the induced expression of FPN1 by cadmium, cells were treated with 25 µM CdCl~2~ in the presence or absence of 0.5 µg/ml actinomycin D for 4 hours. Actinomycin D forms a stable complex with double-stranded DNA, thus inhibiting DNA-primed RNA synthesis, i.e. gene transcription. The results of these experiments showed that actinomycin D treatment alone did not change the steady-state level of FPN1 mRNA in J774 cells. However, increased FPN1 gene expression by cadmium treatment was almost completely blocked when cells were co-treated with actinomycin D ([Fig. 5](#F5){ref-type="fig"}). These results indicate that cadmium up-regulates FPN1 gene expression in a transcription-dependent manner.

To further examine the cadmium-dependent regulation of FPN1 gene transcription, reporter assays using the luciferase expression system were performed. A reporter construct that contained the full-length FPN1 promoter region and luciferase gene were transiently transfected into HeLa cells. 24 hours after transfection, cells were treated with 0 to 25 µM CdCl~2~ for 8 hours and the luciferase activity of cell lysates was measured using a luminometer. [Fig. 6](#F6){ref-type="fig"} shows that cadmium treatment greatly increased luciferase activity in a dose-dependent manner, suggesting that cadmium loading into macrophage cells stimulates the promoter activity of the FPN1 gene.

Role of ROS in the cadmium-mediated FPN1 expression in J774 macrophage cells
----------------------------------------------------------------------------

To investigate the possibility that cadmium-induced oxidative stress may play a role in the up-regulation of FPN1 gene expression, we first examined whether intracellular ROS production was increased in cadmium loaded J774 macrophage cells. The ROS production in J774 cells was determined using H~2~DCFDA fluorescence. As shown in [Fig. 7](#F7){ref-type="fig"}, cadmium treatment significantly increased ROS levels by more than 2-fold compared to the untreated controls (*P* \< 0.05).

We then examined the effects of antioxidant NAC treatment on cadmium-induced FPN1 mRNA expression. J774 cells were pretreated in the presence or absence of 1 mM NAC for 30 min and then further treated with or without 25 µM CdCl~2~ for 8 hours. Results showed that cadmium treatment alone decreased the intracellular GSH/GSSH ratio to less than half of that found in the untreated controls. When cells were co-treated with NAC, the intracellular GSH/GSSG ratio was recovered to the levels of the untreated controls ([Fig. 8A](#F8){ref-type="fig"}). Furthermore, increased FPN1 mRNA expression by cadmium treatment was attenuated when cells were co-treated with NAC ([Fig. 8B, C](#F8){ref-type="fig"}).

Discussion
==========

Cadmium intoxication has been associated with the dysregulation of iron homeostasis, which suggests that the expression of iron regulatory proteins can be affected by cadmium stress. In the present study, we clearly demonstrated that cadmium loading into macrophage cells significantly increased FPN1 mRNA levels in a dose- and time-dependent manner. Furthermore, cadmium-induced FPN1 mRNA expression was associated with increased levels of FPN1 protein in macrophages. FPN1 is a key iron exporter in macrophages and iron release from macrophages plays an important role in maintaining iron homeostasis ([@B3]). Therefore, it is possible that elevated concentrations of cadmium result in excess iron release from macrophage cells and disrupt iron homeostasis in the body. In addition, the potent positive effects of cadmium on FPN1 levels suggest that cadmium may also be a transport substrate for export by FPN1. Likewise, DMT1, an iron importer, was shown to be capable of transporting various divalent metals including cadmium ([@B11]). The increased levels of FPN1 in macrophages could result in the acceleration of cadmium export into the circulating system, which would potentiate its toxicity.

In the present study, we showed that cadmium-mediated FPN1 mRNA induction in J774 cells was completely blocked when cells were co-treated with a transcription inhibitor actinomycin D. Moreover, the transactivational activity of the FPN1 promoter was directly stimulated by cadmium loading. Taken together, these results demonstrate that cadmium loading into macrophages up-regulates FPN1 gene expression in a transcription-dependent manner. Cadmium has been shown to regulate the transcription of genes that encode a variety of different types of proteins, including metallothionein, heat shock protein, tumor necrosis factor, heme oxygenase-1, etc. ([@B4]; [@B21]; [@B38]). Cadmium can act as a strong ligand for a transcription factor called MTF (metal response element (MRE)-binding transcription factor-1), which binds to MRE in the promoter region of cadmium-regulated genes. However, it is not clear whether the FPN1 gene contains functional MREs in its promoter region. In addition, previous studies have shown that zinc, another potent activator of MTF, didn\'t enhance FPN1 mRNA levels in macrophages ([@B6]; [@B25]). Therefore, it is likely that regulation of FPN1 gene expression by cadmium is independent of the MTF-MRE system.

We found that cadmium loading into macrophage cells significantly increased intracellular ROS production. Similar to our observation, treatment of microglia cells, resident macrophages of the brain, with cadmium was shown to induce oxidative stress as assessed by increased DMPO-trapped electron spin resonance (ESR) signals and intracellular ROS levels ([@B38]). The ability of cadmium to induce ROS formation has also been described by other studies in different cell types ([@B20]; [@B35]). Furthermore, it was reported that *in vivo* cadmium exposure also led to excessive production of ROS in mouse peritoneal macrophages ([@B28]). Since cadmium is a divalent ion at physiological pH, it is unlikely that the metal directly generates ROS. In the present study, we demonstrated that cadmium treatment significantly decreased the GSH/GSSG ratio. Our results are consistent with previous studies, which reported that cadmium exposure resulted in GSH depletion and increased oxidative stress in brain cells and murine thymocyts ([@B14]; [@B22]; [@B24]; [@B26]). GSH is the predominant antioxidant in the cytoplasm of cells and can scavenge ROS. Therefore, it appears that cadmium indirectly increases intracellular ROS levels through the depletion of antioxidant molecules.

To further investigate whether the cadmium-induced oxidative stress is associated with changes in FPN1 mRNA, we treated J774 cells with the antioxidant NAC. NAC is an important inducer of intracellular glutathione and has been shown to be a ROS scavenger ([@B10]; [@B32]). In the present study, we found that the intracellular GSH/GSSG ratio was increased when J774 cells were co-treated with cadmium and NAC, compared to when cells were treated with cadmium alone. More importantly, cadmium-induced FPN1 mRNA expression was markedly attenuated when cells were co-treated with NAC. The results of the present study strongly indicate that cadmium enhances FPN1 gene transcription via increased production of ROS. Several proteins that are related to iron metabolism are shown to be redox sensitive. For example, H~2~O~2~ treatment significantly increased the levels of the transferrin receptor (TfR), the major iron uptake protein ([@B34]). Also, it is well known that the expression of ferritin, the major iron storage protein, can be modulated in response to a battery of different oxidative stressors such as H~2~O~2~, *tert*-butylhydroquinone, hemin, and UV-irradiation ([@B12]; [@B16]; [@B36]; [@B37]). Both TfR and ferritin transcripts contain an iron responsive element (IRE), where iron regulatory proteins (IRP1 and IRP2) can specifically bind to. IRPs are proposed as sensors of ROS, since their activities are readily changed by ROS. The mRNA of FPN1 also contains putative IREs in its 5\'-untranslated region. Thus, further studies are needed to determine whether the IRP/IRE system is involved in cadmium-induced FPN1 expression.

In summary, the results of this study clearly demonstrate that cadmium significantly increased the expression of iron exporter FPN1 in macrophages, suggesting another important interaction between cadmium and iron metabolism. The interaction of cadmium and iron metabolism has also been shown in other cell types such as enterocytes ([@B29]). Future studies are warranted to investigate the physiological consequences of cadmium-induced FPN1 expression on iron homeostasis and cadmium toxicity.

Supported by Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2004-204-C00091).

![**Effects of cadmium treatment on the viability of J774 macrophage cells.** J774 cells were treated with CdCl~2~ with indicated concentrations and time. The cell viability was measured by MTT assay as described in Methods and Materials. Data shown are mean ± SD (n=6). ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g001){#F1}

![**Effects of cadmium treatment with various concentrations on FPN1 mRNA levels in J774 cells.** J774 cells were incubated with the indicated concentrations of CdCl~2~ for 8 h. Total RNA were prepared and analyzed for FPN1 or β-actin mRNA by RT-PCR analyses. Data shown are representative agarose gels (*upper panel*) or means ± SD of three independent experiments (*lower panel*). ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g002){#F2}

![**Effects of cadmium treatment with various incubation time on FPN1 mRNA levels in J774 cells.** J774 cells were incubated with 25 µM CdCl~2~ for the indicated time. Total RNA were prepared and analyzed for FPN1 or β-actin mRNA by RT-PCR analyses. Data shown are representative agarose gels (*upper panel*) or means ± SD of three independent experiments (*lower panel*). ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g003){#F3}

![**Effects of cadmium treatment on FPN1 protein levels in J774 cells.** J774 cells were incubated with 0, 5, 10, or 25 µM CdSO~4~ for 8 h. Whole cell lysates were prepared and analyzed for FPN1 protein by Western blot. *Upper panel*: representative blot, *Lower panel*: band density detected by chemiluminescence was quantified (QuantityOne imaging software, Bio-Rad). Values are mean ± SD of three independent experiments. ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g004){#F4}

![**Effects of cadmium and actinomycin D on FPN1 mRNA levels in J774 cells.** J774 cells were treated with 25 µM CdCl~2~ for 4 h in the presence or absence of 0.5 µg/ml actinomycin D. Total RNAs were prepared and analyzed for FPN1 or β-actin mRNA by RT-PCR. *Upper panel*: representative agarose gels, *Lower panel*: band intensity detected by ethidium bromide-staining was quantified (QuantityOne imaging software, Bio-Rad). Values are mean ± SD of three independent experiments. ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g005){#F5}

![**Effects of cadmium treatment on the luciferase activity driven by FPN1-promoter.** HeLa cells were transiently transfected with FPN1 promoter/luciferase reporter constructs for 12 h. Cells were treated with 0, 5, 10, or 25 µM CdSO~4~ for another 8 h. Luciferase activity in cell lysates was then determined. Values are presented as mean ± SD of three independent experiments. ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g006){#F6}

![**Effects of cadmium treatment in J774 cells on the reactive oxygen species (ROS) generation.** J774 cells were treated with 25 µM cadmium and intracellular ROS generation was detected by using 2\',7\'-dichlorodihydrofluorescein diacetate (H~2~DCFDA). Values are presented as mean ± SD of three independent experiments. ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g007){#F7}

![**Effects of cadmium and N-acetylcystein (NAC) treatment on FPN1 mRNA levels in J774 cells.** J774 cells were pretreated in the presence or absence of 1 mM NAC for 30 min, and then further treated with or without 25 µM CdCl~2~. Total RNA were prepared and analyzed for FPN1 or β-actin mRNA by RT-PCR analyses. Data shown are representative agarose gels **(A)** or means ± SD of three independent experiments **(B)**. Intracellular GSH/GSSG ratio was measured as described in Methods and Materials **(C)**. ^\*^*P* \< 0.05 vs. untreated controls](nrp-3-192-g008){#F8}
